Life Saving Drugs Program resources – Paroxysmal nocturnal haemoglobinuria
A collection of resources for health professionals to help people with paroxysmal nocturnal haemoglobinuria access eculizumab (Soliris®) under the Life Saving Drugs Program.
Collection description
This collection contains guidelines, forms and documents related to accessing eculizumab (Soliris®) under the Life Saving Drugs Program. Click to view the Soliris® product information on the Therapeutic Goods Administration website.
Guidelines
Life Saving Drugs Program – Paroxysmal nocturnal haemoglobinuria – Guidelines
Forms
Life Saving Drugs Program – Paroxysmal nocturnal haemoglobinuria – Initial application
Life Saving Drugs Program – Paroxysmal nocturnal haemoglobinuria – Reapplication
Life Saving Drugs Program – Paroxysmal nocturnal haemoglobinuria – Patient test results spreadsheet
Medicines review documents
Life Saving Drugs Program – Paroxysmal nocturnal haemoglobinuria – Medicines review protocol
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.